Piffard Marianne, Nubret-Le Coniat Karine, Simon Olivier, Leuillet Sébastien, Rémy Alain, Barandon Laurent, Ouattara Alexandre
Department of Anesthesia and Critical Care, Magellan Medico-Surgical Center, CHU Bordeaux, Bordeaux, France.
INSERM, UMR 1034, Biology of Cardiovascular Diseases, University of Bordeaux, Pessac, France.
Artif Organs. 2020 Feb;44(2):153-161. doi: 10.1111/aor.13540. Epub 2019 Sep 2.
Left ventricular assist devices (LVADs) are used as an alternative therapy for heart transplantation in patients with advanced heart failure. However, the mortality rate of these patients remains relatively high. A large proportion of deaths after LVAD implantation occur during intensive care unit (ICU) stay. We conducted a retrospective study to identify the risk factors for all-cause ICU mortality in patients with an implanted LVAD. Between January 1, 2008 and December 31, 2016, 70 consecutive patients who had received an LVAD were analyzed. The median ICU length of stay was 14 days (IQR: 8-31) and 16 patients (22.9% [95%CI: 13.1-32.7]) died in the ICU. The 90-day mortality rate was 25.7% (95%CI: 15.5-35.9). The main causes of ICU mortality were: multiple organ failure, stroke, and hemorrhagic events. The univariate analysis identified the following perioperative risk factors for all-cause ICU mortality: hypertension, preoperative platelet count, preoperative white cell count, inotropic support before LVAD implantation, mechanical ventilation before LVAD implantation, renal replacement therapy before LVAD implantation, short-term mechanical support before LVAD implantation, INTERMACS class 1 to 2, low intraoperative platelet count, low early postoperative hemoglobin level, low early postoperative platelet count, low early postoperative pH, and massive perioperative blood transfusion. In the multivariate logistic regression analysis, only mechanical ventilation before LVAD implantation was retained as an independent risk factor for ICU mortality (OR = 11.96 [95%CI: 2.67-53.45], P < .01). These findings confirm that most deaths after LVAD implantation occur in the ICU. Patients that receive mechanical ventilation preoperatively have the highest risk of death. This confirms the need to actively treat respiratory failure and to wean patients from respiratory support before LVAD implantation. Such a strategy offers the best opportunity to initiate active rehabilitation.
左心室辅助装置(LVADs)被用作晚期心力衰竭患者心脏移植的替代疗法。然而,这些患者的死亡率仍然相对较高。LVAD植入术后很大一部分死亡发生在重症监护病房(ICU)住院期间。我们进行了一项回顾性研究,以确定植入LVAD患者全因ICU死亡率的危险因素。在2008年1月1日至2016年12月31日期间,对70例连续接受LVAD的患者进行了分析。ICU中位住院时间为14天(四分位间距:8 - 31天),16例患者(22.9% [95%置信区间:13.1 - 32.7])在ICU死亡。90天死亡率为25.7%(95%置信区间:15.5 - 35.9)。ICU死亡的主要原因是:多器官功能衰竭、中风和出血事件。单因素分析确定了以下围手术期全因ICU死亡率的危险因素:高血压、术前血小板计数、术前白细胞计数、LVAD植入前的正性肌力支持、LVAD植入前的机械通气、LVAD植入前的肾脏替代治疗、LVAD植入前的短期机械支持、INTERMACS 1至2级、术中血小板计数低、术后早期血红蛋白水平低、术后早期血小板计数低、术后早期pH值低以及围手术期大量输血。在多因素逻辑回归分析中,只有LVAD植入前的机械通气被保留为ICU死亡率的独立危险因素(比值比 = 11.96 [95%置信区间:2.67 - 53.45],P <.01)。这些发现证实,LVAD植入术后大多数死亡发生在ICU。术前接受机械通气的患者死亡风险最高。这证实了在LVAD植入前积极治疗呼吸衰竭并使患者脱离呼吸支持的必要性。这样的策略为启动积极康复提供了最佳机会。